Medicare part D update - Lessons learned and unfinished business

New England Journal of Medicine

Volumn 361, Issue 4, 2009, Pages 406-

  Neuman, Patricia ^a   Cubanski, Juliette ^a  

^a HENRY J KAISER FAMILY FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SERVICE; LAW ENFORCEMENT; MEDICAL INFORMATION; MEDICARE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW;

EID: 67651151333     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMhpr0809949     Document Type: Article

References (52)

1. Iglehart JK. The new Medicare prescription-drug benefit - a pure power play. N Engl J Med 2004;350:826-33.
2. Altman DE. The new Medicare prescription-drug legislation. N Engl J Med 2004;350:9-10.
3. Pear R. Medicare aide voices doubts on adding drug benefits. New York Times. June 7, 2003.
4. Over 38 million people with Medicare now receiving prescription drug coverage. News release of the Department of Health and Human Services, Washington, DC, June 14, 2006.
5. Data from Centers for Medicare & Medicaid Services. Office of Research, Development and Information, 2004. Prescription for Medicare modernization: Medicare Part D as a model. Presented by van der Walde L at Implications of Medicare Part D. Washington, DC: American Enterprise Institute for Public Policy Research, October 14, 2008. (Accessed July 6, 2009, at http://www.aei.org/docLib/20081015-Lambert.pdf.)
6. Centers for Medicare & Medicaid Services. 2009 Enrollment information, as of February 1, 2009. (Accessed July 6, 2009, at http://www.cms.hhs.gov/PrescriptionDrugCovGenIn/.)
7. Neuman P, Strollo MK, Guterman S, et al. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors. Health Aff (Millwood) 2007;26:w630-w643.
8. Levy H, Weir D. Take-up of Medicare Part D: results from the Health and Retirement Study. NBER working paper no. 14692. Cambridge, MA: National Bureau of Economic Research, January 2009.
9. Regan JF, Petroski CA. Prescription drug coverage among Medicare beneficiaries. Health Care Financ Rev 2007;29(1):119-25.
10. Heiss F, McFadden D, Winter J. Who failed to enroll in Medicare Part D, and why? Early results. Health Aff (Millwood) 2006;25:w344-w354.
11. Hoadley J, Hargrave E, Merrell K, Zhao L. Medicare Part D benefit designs and formularies, 2006-2009. Presentation to the Medicare Payment Advisory Commission. December 5, 2008. (Accessed July 6, 2009, at http://www.medpac.gov/ transcripts/MedPAC%20Formulary%20Presentation%20-%20Hoadley%2012-05- 08%20revised.pdf.)
12. Hargrave E, Hoadley J, Cubanski J, Neuman T. Medicare prescription drug plans in 2009 and key changes since 2006: summary of findings. Washington, DC: Kaiser Family Foundation, June 2009.
13. Heaton E, Carino T, Dix H. Assessing Medicare prescription drug plans in four states: balancing cost and access. Issue brief. New York: Commonwealth Fund, August 2006.
14. Hoadley J, Thompson J, Hargrave E, Cubanski J, Neuman T. Medicare Part D 2009 data spotlight: the coverage gap. Washington, DC: Kaiser Family Foundation, November 2008.
15. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff (Millwood) 2005;Suppl Web Exclusive:W5-152-W5-166.
16. Soumerai SB, Pierre-Jacque M, Zhang F, et al. Cost-related medication nonadherence among elderly and disabled Medicare beneficiaries: a national survey 1 year before the Medicare drug benefit. Arch Intern Med 2006;166:1829-35.
17. Schneeweiss S, Patrick AR, Pedan A, et al. The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Aff (Millwood) 2009;28:w305-w316.
18. Lichtenberg FR, Sun SX. The impact of Medicare Part D on prescription drug use by the elderly. Health Aff (Millwood) 2007;26:1735-44.
19. Ketcham JD, Simon K. Medicare Part D's effects on elderly drug costs and utilization. NBER working paper no. 14326. Cambridge, MA: National Bureau of Economic Research, September 2008.
20. Yin W, Basu A, Zhang JX, Rabbani A, Meltzer DO, Alexander GC. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. Ann Intern Med 2008;148:169-77.
21. Hoadley J, Hargrave E, Cubanski J, Neuman T. The Medicare Part D coverage gap: costs and consequences in 2007. Washington, DC: Kaiser Family Foundation, August 2008.
22. Hoadley J, Thompson J, Hargrave E, Cubanski J, Neuman T. Medicare Part D 2009 data spotlight: premiums. Washington, DC: Kaiser Family Foundation, November 2008.
23. Hargrave E, Hoadley J, Merrell K. Drugs on specialty tiers in Part D. No. 09-1. Washington, DC: Medicare Payment Advisory Commission, February 2009.
24. Centers for Medicare & Medicaid Services. Things to think about when you compare Medicare drug coverage. August 2008. (CMS publication no. 11163.) (Accessed July 6, 2009, at http://www.medicare.gov/Publications/Pubs/pdf/11163. pdf.)
25. Gruber J. Choosing a Medicare Part D plan: are Medicare beneficiaries choosing low-cost plans? Washington, DC: Kaiser Family Foundation, March 2009.
26. Cubanski J, Neuman P. Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage. Health Aff (Millwood) 2007;26:w1-w12.
27. Medicare drug plans strong and growing. Press release of the Centers for Medicare & Medicaid Services, Baltimore, January 30, 2007.
28. Medicare prescription drug benefit's projected costs continue to drop. Press release of the Centers for Medicare & Medicaid Services, Baltimore, January 31, 2008.
29. Avalere Health. On average, beneficiaries in the top 10 PDPs face double-digit percent increases in their monthly premiums in 2009. November 2008. (Accessed July 6, 2009, at http://www.avalerehealth.net/research/docs/ Enrollment-Weighted-Premiums-Top-10-Plans-20081112.pdf.)
30. Dulio A, Perry M, Cubanski J. Voices of beneficiaries: attitudes toward Medicare part D open enrollment for 2008. Washington, DC: Kaiser Family Foundation, December 2007.
31. Summer L, Hoadley J, Hargrave E, Cubanski J, Neuman T. Medicare Part D 2009 data spotlight: low-income subsidy plan availability. Washington, DC: Kaiser Family Foundation, November 2008.
32. Duggan M, Morton FS. The effect of Medicare Part D on pharmaceutical prices and utilization. NBER working paper no. 13917. Cambridge, MA: National Bureau of Economic Research, April 2008.
33. Berndt ER, Frank RG. Medicare Part D and prescription drug prices. Surv Curr Bus 2007;87:59-71.
34. Families USA. No bargain: Medicare drug plans deliver high prices. January 2007. (Accessed July 6, 2009, at http://www.familiesusa.org/assets/pdfs/ no-bargain-medicare-drug.pdf.)
35. Frank RG, Newhouse JP. Should drug prices be negotiated under Part D of Medicare? And if so, how? Health Aff (Millwood) 2008;27:33-43.
36. Office of Inspector General. Comparing pharmacy reimbursement: Medicare Part D to Medicaid. (Publication no. OEI-03-07-00350.) Washington, DC: Department of Health and Human Services, February 2009.
37. U.S. House of Representatives, Committee on Oversight and Government Reform, Majority Staff. Medicare Part D: drug pricing and manufacturer windfalls. July 2008. (Accessed July 6, 2009, at http://oversight.house.gov/ documents/20080724101850.pdf.)
38. Danzon P. Closing the doughnut hole: no easy answers. Health Aff (Millwood) 2004;Suppl Web Exclusives:W4-405-W4-408.
39. Will GF. 'Socialism'? It's already here. Washington Post. November 16, 2008:B7.
40. Aitken M, Berndt ER, Cutler DM. Prescription drug spending trends in the United States: looking beyond the turning point. Health Aff (Millwood) 2009;28:w151-w160.
41. 2004 Annual report of the boards of trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance trust funds. Washington, DC: Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds, March 2004.
42. 2008 Annual report of the boards of trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance trust funds. Washington, DC: Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds, March 2008.
43. 2007 Annual report of the boards of trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance trust funds. Washington, DC: Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds, April 2007.
44. Sisko A, Truffer C, Smith S, et al. Health spending projections through 2018: recession effects add uncertainty to the outlook. Health Aff (Millwood) 2009;28:w346-w357.
45. Madden JM, Graves AJ, Zhang F, et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA 2008;299:1922-8.
46. Raebel MA, Delate T, Ellis JL, Bayliss EA. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D. Med Care 2008;46:1116-22.
47. Zhang Y, Donohue JM, Newhouse JP, Lave JR. The effects of the coverage gap on drug spending: a closer look at Medicare Part D. Health Aff (Millwood) 2009;28:w317-w325.
48. Rice T. Reducing the number of drug plans for seniors: a proposal and analysis of three case studies. Presentation at AcademyHealth Annual Research Meeting. Washington, DC: June 9, 2008.
49. Medicare's troubling drug gap. New York Times. September 2, 2008.
50. Budget options. Vol. 1. Health care. Washington, DC: Congressional Budget Office, December 2008.
51. The White House, Office of the Press Secretary. Remarks by the President on the Medicare Part D "doughnut hole" and AARP endorsement. June 22, 2009. (Accessed July 6, 2009, at http://www.whitehouse.gov/the-press-office/ Remarks-by-the-President-on-the-Medicare-Part-D-Doughnut-Hole-and-AARP- Endorsement/.)
52. U.S. House of Representatives. Text of the House Tri-Committee Health Reform Discussion Draft. June 19, 2009. (Accessed July 6, 2009, at http://waysandmeans.house.gov/media/pdf/111/hrdraft1xml.pdf.)